Clinical and imaging correlates of the multiple sclerosis impact scale in secondary progressive multiple sclerosis

Journal of Neurology

Volumn 259, Issue 2, 2012, Pages 237-245

  Hayton, T ^a   Furby, J ^a   Smith, K J ^a   Altmann, D R ^b   Brenner, R ^c   Chataway, J ^d   Hunter, K ^a   Tozer, D J ^a   Miller, D H ^a   Kapoor, R ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c ROYAL FREE HOSPITAL   (United Kingdom)

^d NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

MRI; MSIS 29; Multiple sclerosis; Secondary progressive

Indexed keywords

LAMOTRIGINE; PLACEBO;

ADULT; AGED; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE DURATION; DOUBLE BLIND PROCEDURE; FEMALE; GRAY MATTER; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICAL CAPACITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SPINAL CORD; STRUCTURED INTERVIEW; WHITE MATTER;

ADULT; ANTICONVULSANTS; CROSS-SECTIONAL STUDIES; DISABILITY EVALUATION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEVERITY OF ILLNESS INDEX; TRIAZINES;

EID: 84860417151     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-011-6151-5     Document Type: Article

References (47)

1. C Confavreux S Vukusic T Moreau P Adelein 2000 Relapses and progression of disability in multiple sclerosis N Engl J Med 343 1430 1438 11078767 10.1056/NEJM200011163432001 1:STN:280:DC%2BD3M%2FisFWnsg%3D%3D
2. E Leray J Yaouanq E Le Page M Coustans D Laplaud J Oger G Edan 2010 Evidence for a two-stage disability progression in multiple sclerosis Brain 133 1900 1913 20423930 10.1093/brain/awq076
3. A Scalfari A Neuhaus A Degenhardt GP Rice A Muraro M Daumer GC Ebers 2010 The natural history of multiple sclerosis, a geographically based study 10: relapses and long-term disability Brain 133 1914 1929 20534650 10.1093/brain/awq118
4. BD Trapp J Peterson RM Ransohoff R Rudick S Mork L Bo 1998 Axonal transection in lesions of multiple sclerosis N Engl J Med 338 278 285 9445407 10.1056/NEJM199801293380502 1:STN:280:DyaK1c%2Fpt1SksA%3D%3D
5. A Kutzelnigg CF Luchinetti C Stadelman W Bruck H Rauschka M Bermann M Schmidbauer JE Parisi H Lassman 2005 Cortical demyelination and diffuse white matter injury in multiple sclerosis Brain 128 2705 2712 16230320 10.1093/brain/awh641
6. DH Miller F Barkhof JA Frank GJM Parker AJ Thompson 2002 Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance Brain 125 1676 1695 12135961 10.1093/brain/awf177
7. DKB Li U Held J Petkau M Daumer F Barkhof F Fazekas JA Frank L Kappos DH Miller JH Simon JS Wolinsky M Filippi and for the Sylvia Lawry Centre for MS Research MRI 2006 T2 lesion burden in multiple sclerosis: a plateauing relationship with clinical disability Neurology 66 1384 1389 16682671 10.1212/01.wnl.0000210506.00078.5c 1:STN:280:DC%2BD283lvVehtw%3D%3D
8. Filippi M, Agosta F. (2007) Magnetization transfer MRI in multiple sclerosis. J Neuroimaging. Suppl 1:22S-26S
9. PM Rothwell D McDowell CK Wong PJ Dornan 1997 Doctors and patients don't agree: cross-sectional study of patients' and doctors' perceptions and assessments of disability in multiple sclerosis BMJ 314 1580 1583 9169401 10.1136/bmj.314.7094.1580 1:STN:280:DyaK2szivFKqtw%3D%3D
10. J Newcombe CP Hawkins CL Henderson HA Patel MN Woodroofe GM Hayes ML Cuzner D MacManus EP du Boulay WI McDonald 1991 Histopathology of multiple sclerosis lesions detected by magnetic resonance imaging in unfixed postmortem central nervous system tissue Brain 114 1013 1023 2043938 10.1093/brain/114.2. 1013
11. RT Naismith AH Cross 2005 Multiple sclerosis and black holes: connecting the pixels Arch Neurol 62 1666 1668 16286537 10.1001/archneur.62.11.1666
12. JF Kurtzke 1983 Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) Neurology 33 1444 1452 6685237 1:STN:280:DyaL2c%2FktValsQ%3D%3D
13. JS Fischer RA Rudick GR Cutter SC Reingold The national MS society clinical outcomes assessment task force 1999 The multiple sclerosis functional composite measure (MSFC): an integrated approach to MS clinical outcome assessment Mult Scler 5 244 250 10467383 1:STN:280:DyaK1MzpvVymsw%3D%3D
14. J Hobart D Lamping R Fitzpatrick A Riazi A Thompson 2001 The multiple sclerosis impact scale: a new patient-based outcome measure Brain 124 962 973 11335698 10.1093/brain/124.5.962 1:STN:280:DC%2BD3M3jvFOgtA%3D%3D
15. A Riazi JC Hobart DL Lamping R Fitzpatrick AJ Thompson 2002 Multiple Sclerosis Impact Scale (MSIS-29): reliability and validity in hospital based samples J Neurol Neurosurg Psychiatr 73 701 704 12438473 10.1136/jnnp.73.6.701 1:STN:280:DC%2BD38jhs1Grtg%3D%3D
16. ELJ Hoogervorst JNP Zwemmer B Jelles CH Polman BMJ Uitdehaag 2004 Multiple Sclerosis Impact Scale (MSIS-29): relation to established measures of impairment and disability Mult Scler 10 569 574 15471375 10.1191/ 1352458504ms1078oa 1:STN:280:DC%2BD2crgt1yltA%3D%3D
17. L Costelloe K O'Rourke C McGuigan C Walsh N Tubridy M Hutchinson 2008 The longitudinal relationship between the patient-reported Multiple Sclerosis Impact Scale and the clinician-assessed Multiple Sclerosis Functional Composite Mult Scler 14 255 258 17942522 10.1177/1352458507081274 1:STN:280: DC%2BD1c7nslSqug%3D%3D
18. R Kapoor J Furby T Hayton KJ Smith DR Altmann R Brenner J Chataway RA Hughes DH Miller 2010 A randomized controlled trial of neuroprotection with lamotrigine in secondary progressive multiple sclerosis Lancet Neurol 9 681 688 20621711 10.1016/S1474-4422(10)70131-9 1:CAS:528:DC%2BC3cXpsFajur4%3D
19. GR Cutter MS Baier RA Rudick DL Cookfair JS Fischer J Petkau K Synulko BG Weinshenker JP Antel C Confavreaux GW Ellison F Lublin AE Miller SM Rao S Reingold A Thompson E Willoughby 1999 Development of a multiple sclerosis functional composite as a clinical trial outcome measure Brain 122 871 882 10355672 10.1093/brain/122.5.871
20. DL Plummer 1992 Dispimage: a display and analysis tool for medical images Revsita Di Neuroradiologica 5 489 495
21. PD Molyneux DH Miller M Filippi TA Yousry EV Radii HJ Ader F Barkhof 1999 Visual analysis of serial T2-weighted MRI in multiple sclerosis: intra- and interobserver reproducibility Neuroradiology 41 882 888 10639661 10.1007/s002340050860 1:STN:280:DC%2BD3c7gtlynsA%3D%3D
22. SM Smith Y Zhang M Jenkinson J Chen PM Matthews A Federico N De Stefano 2002 Accurate, robust and automated longitudinal and cross-sectional brain change analysis Neuroimage 17 479 489 12482100 10.1006/nimg.2002.1040
23. NA Losseff SL Webb JI O'Riordan R Page L Wang GJ Barker PS Tofts WI McDonald DH Miller AJ Thompson 1996 Spinal cord atrophjy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression Brain 119 701 708 8673483 10.1093/brain/119.3.701
24. J Furby T Hayton D Altmann R Brenner J Chataway KJ Smith DH Miller R Kapoor 2010 A longitudinal study of MRI-detected atrophy in secondary progressive multiple sclerosis J Neurol 257 1508 1516 20437181 10.1007/s00415-010-5563-y 1:STN:280:DC%2BC3cjntVejug%3D%3D
25. PD Molyneux L Kappos C Polman C Pozzilli F Barkhof Filippi 2000 The effect of interferon Beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. European Study Group on interferon beta-b in secondary progressive multiple sclerosis Brain 123 2256 2263 11050025 10.1093/brain/123.11.2256
26. CAMMS223 Trial Investigators 2008 Alemtuzumab vs interferon beta -1a in earlt multiple sclerosis N Eng J Med 359 1786 1801 10.1056/NEJMoa0802670
27. T Hayton J Furby KJ Smith DR Altmann R Brenner J Chataway RAC Hughes K Hunter D Tozer DH Miller R Kapoor 2009 Grey matter magnetization transfer ratio independently correlates with neurological deficit in secondary progressive multiple sclerosis J Neurol 256 427 435 19271108 10.1007/s00415-009-0110-4 1:CAS:528:DC%2BD1MXltlKrsrY%3D
28. J Ash burner KJ Friston 2005 Unified segmentation Neuroimage 26 839 851 10.1016/j.neuroimage.2005.02.018
29. NA Losseff L Wang HM Lau DS Yoo ML Gawne-Cain WI McDonald DH Miller AJ Thompson 1996 Progressive cerebral atrophy in multiple sclerosis. A serial MRI study Brain 119 2009 2019 9010005 10.1093/brain/119.6.2009
30. GC Ebers L Heigenhauser M Daumer C Lederer JH Noseworthy 2008 Disability as an outcome in MS clinical trials Neurology 7 624 631 10.1212/01.wnl. 0000313034.46883.16
31. JN Benito-Leon JM Morales JS Rivera-Navarro AJ Mitchell 2003 A review about the impact of multiple sclerosis on health-related quality of life Disabil Rehabil 25 1291 1303 14617435 10.1080/09638280310001608591
32. V Janhardan R Bakshi 2000 Quality of life and its relationship to brain lesions and atrophy on magnetice resonance images in 60 patients with multiple sclerosis Arch Neurol 57 1485 1490 10.1001/archneur.57.10.1485
33. IS Lobentanz S Asenbaum K Vass C Sauter G Klosch H Kollegger W Kristoferitsch J Zeitlhofer 2004 Factors influencing quality of life in multiple sclerosis patients: disability, depressive mood, fatigue and sleep quality Acta Neurol Scand 110 6 13 15180801 10.1111/j.1600-0404.2004.00257.x 1:STN:280:DC%2BD2c3otVKjtA%3D%3D
34. A-K Isaksson G Ahlstrom L-G Gunnarsson 2005 Quality of life in patients with multiple sclerosis J Neurol Neurosurg Psychiatr 76 64 69 15607997 10.1136/jnnp.2003.029660
35. MC Simeoni P Auquier O Fernandez P Flachenecker S Stecchi C Constaninescu E Idiman A Boyko AG Beiske T Vollmer N Triantafylliou P O'Connor Y Barak L Beirmann E Cristiano S Atweh DL Patrick S Robitail N Ammoury A Beresniak J Pelletier on behalf of the MusiQol study group 2008 Validation of the multiple sclerosis international quality of life questionnaire Mult Scler 14 219 230 17942521 10.1177/1352458507080733
36. MW Nordvedt T Riise K-M Myhr HI Nyland 2000 Performance of the SF-36, SF-12 and Rand-36 summary scales in a multiple sclerosis population Med Care 10 1022 1028 10.1097/00005650-200010000-00006
37. SM Gold C Heeson H Schultz U Guder A Monch J Gbadamosi C Buhmann KH Schultz 2001 Disease specific quality of life instruments in multiple sclerosis: validation of the Hamburg Quality of Life Questionnaire in multiple sclerosis (HAQUAMS) Mult Scler 7 119 130 11424632 1:STN:280:DC%2BD3MzmsVWqug%3D%3D
38. J Benito-Leon JM Morales J Riviera-Navarro 2002 European journal of neurology health-related quality of life and its relationship to cognitive and emotional functioning in multiple sclerosis patients Eur J Neurol 9 497 502 12220381 10.1046/j.1468-1331.2002.00450.x 1:STN:280:DC%2BD38vmtFyqtw%3D%3D
39. RH Benedict E Wahlig R Bakshi I Fishman F Munschauer R Zivadinov B Weinstock-Guttman 2005 Predicting quality of life in multiple sclerosis: accounting for physical disability, fatigue, cognition, mood disorder, personality, and behavior change J Neurol Sci 231 29 34 15792817 10.1016/j.jns.2004.12.009
40. AJ Mitchell J Benito-León J-M Morales González J Rivera-Navarro 2005 Quality of life and its assessment in multiple sclerosis: integrating physical and psychological components of wellbeing Lancet Neurol 4 556 566 16109362 10.1016/S1474-4422(05)70166-6
41. C Ytterberg S Johansson LW Holmqvist L von Koch 2008 Longitudinal variations and predictors of increased perceived impact of multiple sclerosis, a two-year study J Neurol Sci 270 53 59 18295236 10.1016/j.jns.2008.01.014
42. EM Mowry A Beheshtian E Waubant DS Goodin BA Cree P Qualley R Lincoln MF George R Gomez SL Hauser DT Okuda D Pelletier 2009 Quality of life in multiple sclerosis is associated with lesion burden and brain volume measures Neurology 72 1760 1765 19451531 10.1212/WNL.0b013e3181a609f8 1:STN:280: DC%2BD1MzlsVSjuw%3D%3D
43. MAA van Walderveen W Kamphorst P Scheltens JHTM van Waesberghe R Ravid J Valk CH Polman F Barkhof 1998 Histopathologic correlate of hypointense spin-echo lesions on Tl-weighted MRI in multiple sclerosis Neurology 50 1282 1288 9595975
44. JHTM van Waesberghe W Kamphorst CJA De Groot MAA van Walderveen JA Castelijns R Ravid GJ Lycklama a Nijeholt P van der Valk CH Polman AJ Thompson F Barkhof 1999 Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability Ann Neurol 46 747 754 10553992 10.1002/1531-8249(199911)46:5<747::AID-ANA10>3.0.CO;2-4
45. E Fisher A Chang RJ Fox JA Tkach T Svarovsky K Nakamura RA Rudick BD Trapp 2007 Imaging correlates of axonal swelling in chronic multiple sclerosis brains Ann Neurol 62 219 228 17427920 10.1002/ana.21113
46. R Bakshi D Czarnecki ZA Shaikh RL Priore V Janardhan Z Kaliszky PR Kinkel 2000 Brain MRI lesions and atrophy are related to depression in multiple sclerosis Neuroreport 11 1153 1158 10817583 10.1097/00001756-200004270-00003 1:STN:280:DC%2BD3c3nsFartg%3D%3D
47. M Codella MA Rocca B Colombo P Rossi G Comi M Filippi 2002 A preliminary study of magnetization transfer and diffusion tensor MRI of multiple sclerosis patients with fatigue J Neurol 249 535 537 12021941 10.1007/s004150200060